Study of MR-107A-02 for the Treatment of Acute Postoperative Pain Following Herniorrhaphy

Completed · Phase 3 · Has a placebo group

Conditions studied: Acute Pain, Post Operative Pain, Pain

In brief

MR-107A-02 is being studied to investigate its efficacy and safety for treatment of acute pain after herniorrhaphy.

Key facts

Study ID

NCT06215859

Run by

Viatris Specialty LLC

People needed

579

Starts

2023-12-29

Expected to finish

2025-03-12

Last updated by the study team

2026-02-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Investigator site 210 — Sheffield, Alabama, United States
• Investigator site 213 — Phoenix, Arizona, United States
• Investigator site 202 — Anaheim, California, United States
• Investigator site 222 — Bakersfield, California, United States
• Investigator site 208 — Riverside, California, United States
• Investigator site 211 — Miami, Florida, United States
• Investigator site 206 — Tampa, Florida, United States
• Investigator site 207 — Atlanta, Georgia, United States
• Investigator site 205 — Wichita, Kansas, United States
• Investigator site 212 — Bellaire, Texas, United States
• Investigator site 215 — Carrollton, Texas, United States
• Investigator site 204 — Houston, Texas, United States
• Investigator site 216 — McAllen, Texas, United States
• Investigator site 219 — San Antonio, Texas, United States
• Investigator site 203 — San Antonio, Texas, United States
• Investigator site 214 — San Antonio, Texas, United States
• Investigator site 201 — Salt Lake City, Utah, United States
• Investigator site 224 — Eau Claire, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.